Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Clinical and Vaccine Immunology : CVI
|
September 5, 2014
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato
Nina Wressnigg, P Noel Barrett, Eva-Maria Pöllabauer, et al.
Science (New York, N.Y.)
|
October 25, 2008
Receptor-like kinase ACR4 restricts formative cell divisions in the Arabidopsis root
Ive De Smet, Valya Vassileva, Bert De Rybel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
Bimodular auxin response controls organogenesis in Arabidopsis
Ive De Smet, Steffen Lau, Ute Voss, et al.
The Lancet. Infectious Diseases
|
December 24, 2016
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial
Michael Schwameis, Thomas Kündig, Gustave Huber, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Clinical and Vaccine Immunology : CVI
|
September 5, 2014
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato
Nina Wressnigg, P Noel Barrett, Eva-Maria Pöllabauer, et al.
Science (New York, N.Y.)
|
October 25, 2008
Receptor-like kinase ACR4 restricts formative cell divisions in the Arabidopsis root
Ive De Smet, Valya Vassileva, Bert De Rybel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
Bimodular auxin response controls organogenesis in Arabidopsis
Ive De Smet, Steffen Lau, Ute Voss, et al.
The Lancet. Infectious Diseases
|
December 24, 2016
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial
Michael Schwameis, Thomas Kündig, Gustave Huber, et al.
Page
of 8